Conversion to Nonexclusive License Sample Clauses

Conversion to Nonexclusive License. LICENSEE may at its sole option, notify LICENSOR in writing at least thirty (30) days prior to December 31 of any calendar year, of its intent to convert the right and license granted in Paragraph 2.1 to a nonexclusive license for all subsequent years; whereupon, the right and license granted in Paragraph 2.1 shall become nonexclusive on January 31 of the following year, and payment of the minimum amount specified in Paragraph 5.2 will not be required for such following year and all subsequent years. Upon receipt of such notice, LICENSOR shall have the immediate right to grant exclusive or nonexclusive licenses to third parties effective February 1 of such following year, subject to LICENSEE's retention of a nonexclusive license during the term of this Agreement provided that LICENSEE meets the minimum 10% requirement specified in Paragraph 3.4. LICENSEE may reestablish its exclusive right and license at any time during the term of this Agreement by written notice to LICENSOR of its intent to do so accompanied by payment to LICENSOR of the full sum of the additional amounts specified in Paragraph 5.2 for all years in which the minimum amount was not paid; provided, however, LICENSEE's reestablished exclusive right and license shall be subject to any and all rights and licenses granted by LICENSOR to third parties during the period in which LICENSEE retained only a nonexclusive license. In addition, LICENSOR shall have the right to convert the exclusive license to a nonexclusive license if LICENSEE fails to have in place in the Field, the minimum number of royalty generating installations specified in Exhibit II.
AutoNDA by SimpleDocs
Conversion to Nonexclusive License. 7.1 In the event ANTHRA shall default in payment of any minimum royalty due under Article 4.2, DFCI may notify ANTHRA and if the default is not remedied within ninety (90) days after the date of notice, then, whether it is during the period of exclusivity or non-exclusivity of the license to ANTHRA, DFCI shall have the right to terminate ANTHRA's license under this Agreement by a second notice to ANTHRA. A default by ANTHRA in payment of the minimum or running royalty under Articles 4.1 and 4.2 or any other default by ANTHRA shall be subject to the provision of Article 11.
Conversion to Nonexclusive License. In lieu of terminating this Agreement under Section 10.2(b) above, VGE may, in its sole discretion, elect to convert this Agreement and the rights hereunder to a nonexclusive license for the remainder of the applicable Initial Term or Renewal Term, in which event such nonexclusive license shall be subordinate to the grant thereafter by VGE of any rights therein to a Third Party and the provisions of Section 2.3 of this Agreement shall upon and coincident therewith be and become thereafter null and void as and to the extent otherwise applicable to VGE or any Affiliate thereof or any third party acting for and on behalf of VGE or any such Affiliate.
Conversion to Nonexclusive License. In lieu of terminating this Agreement under Section 10.2(b) above, IPA China may, in its sole discretion, elect to convert this Agreement and the rights hereunder to a nonexclusive license for the remainder of the applicable Initial Term or Renewal Term, in which event such nonexclusive license shall be subordinate to the grant thereafter by IPA China of any rights therein to a Third Party and the provisions of Section 2.3 of this Agreement shall upon and coincident therewith be and become thereafter null and void as and to the extent otherwise applicable to IPA China or any Affiliate thereof or any third party acting for and on behalf of IPA China or any such Affiliate.
Conversion to Nonexclusive License. In the event that PHARMAVITE fails to purchase the amount set forth in Section 4.1 in any applicable period, and fails to take the actions noted in Section 4.2, then PHARMAVITE shall retain the License but on a non-exclusive basis.

Related to Conversion to Nonexclusive License

  • Exclusive License Licensor hereby grants to Licensee and Licensee hereby accepts from Licensor, upon the terms and conditions herein specified, a sole and exclusive license under the Licensed Patent Rights in the Territory, and in the Field of Use to develop, make, have made, import, have imported, use, offer to sell, sell and otherwise commercialize Licensed Product(s).

  • Nonexclusivity of Rights Nothing in this Agreement shall prevent or limit the Executive's continuing or future participation in any plan, program, policy or practice provided by the Company or any of its affiliated companies and for which the Executive may qualify, nor shall anything herein limit or otherwise affect such rights as the Executive may have under any contract or agreement with the Company or any of its affiliated companies. Amounts which are vested benefits or which the Executive is otherwise entitled to receive under any plan, policy, practice or program of or any contract or agreement with the Company or any of its affiliated companies at or subsequent to the Date of Termination shall be payable in accordance with such plan, policy, practice or program or contract or agreement except as explicitly modified by this Agreement.

  • Non-Exclusive License Grant Subject to the terms and conditions of this Agreement, Takeda hereby grants to Licensee a non-exclusive, sublicensable (subject to Section 3.3 (Sublicensing)) right and license under the Takeda Technology and Takeda’s interest in the Joint Technology to: (a) Develop the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Men’s Health Field in the Takeda Territory solely for the purpose of Exploiting such Licensed Products in the Field in the Licensee Territory, or as required in order for Licensee to comply with its diligence obligations set forth in Section 5.2 (Development Diligence Obligations) and (b) Manufacture the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Takeda Territory.

  • Exclusive License Grant Subject to the terms and conditions of this Agreement, Licensee hereby grants to Takeda an exclusive, sublicensable (subject to Section 3.3 (Sublicensing)), royalty-bearing right and license under the Licensee Technology and Licensee’s interest in the Joint Technology to Exploit the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Field in the Takeda Territory.

  • Non-Exclusive License NCPS grants Company a revocable, non-exclusive, non-transferable and non-sublicensable license during the Term to view-only access the PPEX ATS through the PPEX Site and its related software and other applications and technology for the sole purpose of viewing information about Company and Company Securities and Trades of Company Securities. This license is in addition to the license Company has and is required to maintain during the Term (as defined below) with NCPS’s affiliate, North Capital Investment Technology, Inc., for TransactAPI pursuant to a separate Software and Services License Agreement (“SSLA”). The technology covered by the licenses outlined in this Section 2 is collectively referred to herein as the “Technology”.

  • Nonexclusivity The indemnification provided by this Agreement shall not be deemed exclusive of any rights to which Indemnitee may be entitled under the Company’s Certificate of Incorporation, its Bylaws, any agreement, any vote of stockholders or disinterested members of the Company’s Board of Directors, the General Corporation Law of the State of Delaware, or otherwise, both as to action in Indemnitee’s official capacity and as to action in another capacity while holding such office. The indemnification provided under this Agreement shall continue as to Indemnitee for any action taken or not taken while serving in an indemnified capacity even though he or she may have ceased to serve in any such capacity at the time of any action, suit or other covered proceeding.

  • Nonexclusivity, Etc The rights of the Indemnitee hereunder shall be in addition to any other rights Indemnitee may have under the Company's Amended and Restated Bylaws or the Delaware General Corporation Law or otherwise. To the extent that a change in the Delaware General Corporation Law (whether by statute or judicial decision) permits greater indemnification by agreement than would be afforded currently under the Company's Amended and Restated Bylaws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change.

  • Remedies Cumulative, Concurrent and Nonexclusive Mortgagee shall have all rights, remedies and recourses granted in the Credit Documents and available at law or equity (including the UCC), which rights (a) shall be cumulated and concurrent, (b) may be pursued separately, successively or concurrently against Mortgagor or others obligated under the Credit Documents, or against the Mortgaged Property, or against any one or more of them, at the sole discretion of Mortgagee or the Lenders, (c) may be exercised as often as occasion therefor shall arise, and the exercise or failure to exercise any of them shall not be construed as a waiver or release thereof or of any other right, remedy or recourse, and (d) are intended to be, and shall be, nonexclusive. No action by Mortgagee or the Lenders in the enforcement of any rights, remedies or recourses under the Credit Documents or otherwise at law or equity shall be deemed to cure any Event of Default.

  • Grant of Exclusive License 1. Licensor hereby grants to Licensee an exclusive worldwide license with the right to sublicense others, to make, have made, use, sell and lease the Products described in the Licensed Patent Rights with reach-through rights reserved to Licensor.

  • Term of License Unless terminated earlier, this Agreement will expire without notice on the date set forth on the Rider. You acknowledge and agree that this Agreement is non-renewable and that this Agreement confers upon you absolutely no rights of license renewal whatsoever following the expiration of the License Term.

Time is Money Join Law Insider Premium to draft better contracts faster.